Serial Number 90647331
Registration 6816378
700

Registration Progress

Application Filed
Apr 15, 2021
Under Examination
Dec 14, 2021
Approved for Publication
Oct 19, 2021
Published for Opposition
Oct 19, 2021
Registered
Aug 9, 2022

Trademark Image

Basic Information

Serial Number
90647331
Registration Number
6816378
Filing Date
April 15, 2021
Registration Date
August 9, 2022
Published for Opposition
October 19, 2021
Drawing Code
2

Status Summary

Current Status
Active
Status Code
700
Status Date
Aug 9, 2022
Registration
Registered
Classes
005 040 042 044

Rights Holder

BEONE MEDICINES I GMBH

16
Address
AESCHENGRABEN 27
BASEL 4051
CH

Ownership History

BeiGene, Ltd.

Original Applicant
99
Grand Cayman KY

BeiGene, Ltd.

Owner at Publication
99
Grand Cayman KY

BeiGene, Ltd.

Original Registrant
99
San Mateo, CA

BEONE MEDICINES LTD.

New Owner After Registration #1
16
BASEL CH

BG NC 1, LTD.

New Owner After Registration #2
16
GRAND CAYMAN KY

BEONE MEDICINES I GMBH

New Owner After Registration #3
16
BASEL CH

Legal Representation

Attorney
Kristen S. Ruisi

USPTO Deadlines

Next Deadline
964 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20220809)
Due Date
August 09, 2028
Grace Period Ends
February 09, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

32 events
Date Code Type Description Documents
Oct 29, 2025 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Oct 29, 2025 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Jul 10, 2025 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Jul 9, 2025 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
Mar 24, 2023 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Mar 24, 2023 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Mar 24, 2023 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Dec 8, 2022 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Dec 8, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Dec 8, 2022 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Dec 8, 2022 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Dec 8, 2022 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Aug 9, 2022 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Aug 9, 2022 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jul 8, 2022 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Jul 7, 2022 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Jun 1, 2022 DMCC I DATA MODIFICATION COMPLETED Loading...
Jun 1, 2022 ALIE A ASSIGNED TO LIE Loading...
May 26, 2022 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
May 12, 2022 IUAF S USE AMENDMENT FILED Loading...
May 26, 2022 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
May 26, 2022 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
May 12, 2022 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Dec 14, 2021 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Oct 19, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 19, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
Sep 29, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Sep 13, 2021 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 8, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
Jul 23, 2021 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Jul 22, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 19, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; chemico-pharmaceutical preparations for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; drugs in the nature of pharmaceutical preparations for medical purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; biological preparations for medical purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; chemical preparations for pharmaceutical purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; medicines for human purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; chemical preparations for medical purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; Injectable pharmaceuticals for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; crude drugs in the nature of pharmaceutical preparations for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; Biochemical preparations for medical use for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases
First Use Anywhere: Sep 20, 2021
First Use in Commerce: Sep 20, 2021
Class 040
Custom manufacturing services in the nature of chemical processing and production of medicines and pharmaceuticals for the treatment of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases
First Use Anywhere: Sep 20, 2021
First Use in Commerce: Sep 20, 2021
Class 042
Research and development of new products for others; technological research in the field of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; chemical research; conducting clinical trials for others for the treatment of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; biological research; quality control for the treatment of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; electronic data storage; material testing; cloud computing featuring software for use in database management, word processing, spreadsheet management, tracking; packaging design
First Use Anywhere: Sep 20, 2021
First Use in Commerce: Sep 20, 2021
Class 044
Telemedicine services; health care; convalescent home services; physical therapy services; health counseling; pharmacy advice, namely, pharmaceutical advice
First Use Anywhere: Sep 20, 2021
First Use in Commerce: Sep 20, 2021

Additional Information

Design Mark
The mark consists of a shaded square in red with a stylized square and a star in the center of the stylized square.
Color Claim
The color(s) red is/are claimed as a feature of the mark.

Classification

International Classes
005 040 042 044